A Vaccine Meets Its Promise: Success in Controlling Epidemic Meningitis in Sub-Saharan Africa

Luis Sambo¹, Margaret Chan², Steve Davis³, Anthony Lake⁴, Seth Berkley⁵, Cyrus Poonawalla⁶, Christopher J Elias⁷

Affiliations

¹ World Health Organization, Regional Office for Africa, Brazzaville, Republic of Congo.
² World Health Organization, Geneva, Switzerland.
³ PATH, Seattle, Washington.
⁴ United Nations Children's Fund, New York, New York.
⁵ Gavi, Geneva, Switzerland.
⁶ Serum Institute of India Ltd, Pune.
⁷ Bill & Melinda Gates Foundation, Seattle, Washington.

PMID: 26553663
PMCID: PMC4639480
DOI: 10.1093/cid/civ490

A Vaccine Meets Its Promise: Success in Controlling Epidemic Meningitis in Sub-Saharan Africa

Luis Sambo et al. Clin Infect Dis. 2015.

. 2015 Nov 15;61 Suppl 5(Suppl 5):S387-8.

doi: 10.1093/cid/civ490.

Authors

Luis Sambo¹, Margaret Chan², Steve Davis³, Anthony Lake⁴, Seth Berkley⁵, Cyrus Poonawalla⁶, Christopher J Elias⁷

Affiliations

¹ World Health Organization, Regional Office for Africa, Brazzaville, Republic of Congo.
² World Health Organization, Geneva, Switzerland.
³ PATH, Seattle, Washington.
⁴ United Nations Children's Fund, New York, New York.
⁵ Gavi, Geneva, Switzerland.
⁶ Serum Institute of India Ltd, Pune.
⁷ Bill & Melinda Gates Foundation, Seattle, Washington.

PMID: 26553663
PMCID: PMC4639480
DOI: 10.1093/cid/civ490

No abstract available

Keywords: epidemic; group A meningococcal meningitis; herd protection; public/private partnership; vaccine.

PubMed Disclaimer

Cited by

Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges.
Mustapha MM, Harrison LH. Mustapha MM, et al. Hum Vaccin Immunother. 2018 May 4;14(5):1107-1115. doi: 10.1080/21645515.2017.1412020. Epub 2018 Jan 16. Hum Vaccin Immunother. 2018. PMID: 29211624 Free PMC article. Review.
Large Outbreak of Neisseria meningitidis Serogroup C - Nigeria, December 2016-June 2017.
Nnadi C, Oladejo J, Yennan S, Ogunleye A, Agbai C, Bakare L, Abdulaziz M, Mohammed A, Stephens M, Sumaili K, Ronveaux O, Maguire H, Karch D, Dalhat M, Antonio M, Bita A, Okudo I, Nguku P, Novak R, Bolu O, Shuaib F, Ihekweazu C. Nnadi C, et al. MMWR Morb Mortal Wkly Rep. 2017 Dec 15;66(49):1352-1356. doi: 10.15585/mmwr.mm6649a3. MMWR Morb Mortal Wkly Rep. 2017. PMID: 29240724 Free PMC article.
Bacterial Meningitis Epidemiology in Five Countries in the Meningitis Belt of Sub-Saharan Africa, 2015-2017.
Soeters HM, Diallo AO, Bicaba BW, Kadadé G, Dembélé AY, Acyl MA, Nikiema C, Sadji AY, Poy AN, Lingani C, Tall H, Sakandé S, Tarbangdo F, Aké F, Mbaeyi SA, Moïsi J, Paye MF, Sanogo YO, Vuong JT, Wang X, Ronveaux O, Novak RT; MenAfriNet Consortium. Soeters HM, et al. J Infect Dis. 2019 Oct 31;220(220 Suppl 4):S165-S174. doi: 10.1093/infdis/jiz358. J Infect Dis. 2019. PMID: 31671441 Free PMC article.
Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign.
Diallo AO, Soeters HM, Yameogo I, Sawadogo G, Aké F, Lingani C, Wang X, Bita A, Fall A, Sangaré L, Ouédraogo-Traoré R, Medah I, Bicaba B, Novak RT; MenAfriNet Consortium. Diallo AO, et al. PLoS One. 2017 Nov 2;12(11):e0187466. doi: 10.1371/journal.pone.0187466. eCollection 2017. PLoS One. 2017. PMID: 29095907 Free PMC article.
Meningococcal quadrivalent tetanus toxoid conjugate vaccine (MenACWY-TT, Nimenrix™): A review of its immunogenicity, safety, co-administration, and antibody persistence.
Assaf-Casals A, Dbaibo G. Assaf-Casals A, et al. Hum Vaccin Immunother. 2016 Jul 2;12(7):1825-37. doi: 10.1080/21645515.2016.1143157. Epub 2016 Feb 22. Hum Vaccin Immunother. 2016. PMID: 26900984 Free PMC article. Review.

See all "Cited by" articles

References

1. LaForce FM, Okwo-Bele JM. Eliminating epidemic group A meningococcal meningitis in Africa through a new vaccine. Health Aff (Millwood) 2011; 30:1049–57. - PubMed
1. Novak RT, Kambou JL, Diomandé FV et al. . Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data. Lancet Infect Dis 2012; 12:757–64. - PMC - PubMed
1. Kristiansen PA, Diomandé F, Ba AK et al. . Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity. Clin Infect Dis 2012; 56:354–63. - PubMed
1. Daugla DM, Gami JP, Gamougam K et al. . Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community trial. Lancet 2013; 383:40–7. - PMC - PubMed
1. World Health Organization. Meningococcal A conjugate vaccine: updated guidance, February 2015. Wkly Epidemiol Rec 2015; 90:57–68. - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

001/WHO_/World Health Organization/International

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

A Vaccine Meets Its Promise: Success in Controlling Epidemic Meningitis in Sub-Saharan Africa

Affiliations

A Vaccine Meets Its Promise: Success in Controlling Epidemic Meningitis in Sub-Saharan Africa

Authors

Affiliations

Similar articles

Cited by

References

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources